(Q40817746)

24 September 2017

title

Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity (English)

1 reference

24 September 2017

0 references

0 references

Aoki K

1

1 reference

24 September 2017

Kurooka M

2

1 reference

24 September 2017

Chen JJ

3

1 reference

24 September 2017

Petryniak J

4

1 reference

24 September 2017

Nabel EG

5

1 reference

24 September 2017

Nabel GJ

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 September 2017

1 reference

24 September 2017

volume

2

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

333-337

1 reference

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

24 September 2017

cites work

1 reference

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

21 January 2018

1 reference

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

21 January 2018

1 reference

21 January 2018

1 reference

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

21 January 2018

1 reference

Inhibition of the alloantibody response by CD95 ligand

21 January 2018

1 reference

Metalloproteinase-mediated release of human Fas ligand

21 January 2018

1 reference

Downregulation of Fas ligand by shedding

21 January 2018

1 reference

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

Comparative molecular modelling of the Fas-ligand and other members of the TNF family

21 January 2018

1 reference

Characterization of Fas (Apo-1, CD95)-Fas ligand interaction

21 January 2018

1 reference

Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells

21 January 2018

1 reference

Vitronectin is not essential for normal mammalian development and fertility.

21 January 2018

1 reference

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization

21 January 2018

1 reference

Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor

21 January 2018

1 reference

Regulation of the proinflammatory effects of Fas ligand (CD95L).

21 January 2018

1 reference

Polymorphism of murine Fas ligand that affects the biological activity

21 January 2018

1 reference

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

21 January 2018

1 reference

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

7 January 2021

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

7 January 2021

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

1 reference

7 January 2021

Fas ligand in human serum

1 reference

7 January 2021

Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo

1 reference

7 January 2021

Soluble Fas ligand expression in the ocular fluids of uveitis patients

1 reference

7 January 2021

Identifiers

DOI

10.1038/86336

1 reference

24 September 2017

1 reference